Alessandro Bombaci (Vita-Salute San Raffaele University, Italy) and colleagues reported findings from their study using sandwich-ELISA to quantify plasma peripherin (PRPH) from 120 patients with MND (100 with ALS), 73 MND mimics, and 38 healthy controls.
They found that plasma PRPH concentrations differed significantly among groups (p 0.0001), showing higher values in MND participants than MND mimics and controls, which persisted after adjusting for age and sex. Receiver Operating Characteristic (ROC) curve analysis showed that PRPH discriminated MND from MND mimics (AUC = 0.85), and elevated PRPH correlated positively with revised ALS Functional Rating Scale and lower motor neuron index.
The findings suggest that PRPH could differentiate MND, particularly ALS, from MND mimics, and may have potential prognostic utility.
Source: The Lancet
